Articles & resources
Cornerstone articles written for patients trying to make sense of this disease. No SEO filler, no rewritten dermatology textbooks — just the things we end up explaining most often in clinic, written down once.
Most HS patients are first diagnosed with something else. Here is the pattern that distinguishes HS from a recurrent abscess, pilonidal disease, or a fistula — and why getting that distinction right changes the entire treatment plan.
Read the article →Hurley stage is the single most useful number in HS care. Here is what each stage means in plain language, why a patient can be different stages in different regions, and how staging shapes the conversation about treatment.
Read the article →HS is a follicular disease with structural damage layered on top. Treating one without the other is a recipe for recurrence. Here is why the two-laser protocol uses 1064 nm Nd:YAG and 1470 nm intralesional diode as complements, not alternatives.
Read the article →Biologics and surgery are not competing options in HS — they answer different parts of the disease. Here is how we think about sequencing them, when one should come before the other, and what the handoff between dermatology and surgery should look like.
Read the article →Most of our patients travel in for treatment. Here is how the logistics actually work — consultation by video, procedure scheduling, length of stay, recovery before flying home, and what to set up before you arrive.
Read the article →Perianal HS is one of the most under-recognized presentations. It is regularly treated as a fistula, a pilonidal sinus, or a recurrent perianal abscess for years. Here is how to recognize it and why the surgical plan looks different from disease elsewhere.
Read the article →Not every new lesion after treatment is a setback. Flares are part of HS — even well-controlled HS — and recognizing the difference between a flare and a real change in disease trajectory matters for what you do next.
Read the article →An honest summary of the published evidence base for laser treatment of hidradenitis suppurativa — what is well supported, what is preliminary, and what remains unknown for both 1064 nm Nd:YAG follicle-directed therapy and 1470 nm intralesional tunnel closure.
Read the article →Hidradenitis suppurativa carries a psychological burden that is rarely named in the exam room — chronic pain, stigma, social isolation, intimacy strain, and an elevated rate of depression and anxiety. An honest look at what patients live with, and where support exists alongside medical care.
Read the article →A patient-empowerment checklist for any consultation about surgical or laser treatment of hidradenitis suppurativa — twelve concrete questions that surface what a clinician is actually proposing, how durable it tends to be, and what happens if it does not work.
Read the article →A note on the writing
New articles are added as they're written, not on a marketing calendar. If there's a question you keep running into and don't see answered here, tell us at consultation — those are usually the next pieces.
Next step
A short intake gets reviewed by our team within one business day.
Typical response within one business day. We will never share your information.